International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) | MicrobiomeTrials← Back to trialsNCT07476729
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-09-01Est. Completion: 2033-03-31
Enrollment target: 750 participants Locations- St. Anna Kinderspital GmbH, Vienna, Austria
- Ghent University Hospital, Ghent, Belgium
- Fakultni Nemocnice V Motole, Prague, Czechia
- Rigshospitalet, Copenhagen, Denmark
- HUS Helsinki University Hospital, Helsinki, Finland
- CHU de NICE, Hôpital L'ARCHET, Nice, France
- Charité - Universitätsmedizin Berlin, Berlin, Germany
- Semmelweis University, Budapest, Hungary
- Tel Aviv Sourasky Medical Centre Dana-Dwek Children's Hospital, Tel Aviv, Israel
- Ospedale Pediatrico Bambino Gesu, Rome, Italy
- Prinses Máxima Centrum, Utrecht, Netherlands
- Oslo University Hospital, Oslo, Norway
- University Wroclaw, Wroclaw, Poland
- Instituto Português de Oncologia de Lisboa, Lisbon, Portugal
- Fundeni Clinical Institute, Pediatric Clinic Fundeni, Bucharest, Romania
- Univerzity Komenského a Národného, Bratislava, Slovakia
- University Medical Centre Ljubljana, Ljubljana, Slovenia
- University Clinical Hospital Virgen De La Arrixaca, Murcia, Spain
Other microbiome trials you might be interested in
Relapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaB-cell Acute Lymphoblastic LeukemiaPediatric CancerPediatric ALL, RelapsedPediatric ALLPediatric ALL, B CellAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaPediatric AMLR/R AMLR/R B-cell ALL
The goal of this clinical trial is to learn if sonrotoclax (BGB-11417) is safe and may help treat children and adolescen…
Multiple LocationsEst. completion Apr 30, 2030
Karolinska University Hospital, Solna, SwedenUniversity Children's Hospital, Zurich, SwitzerlandAcıbadem University, Istanbul, Turkey (Türkiye)Phase 1
Recruiting
B-AllAcute Lymphoblastic Leukemia
Background:
B-cell acute lymphoblastic leukemia (B-ALL) is a type of blood cancer. Some people with B-ALL have a gene m…
Bethesda, United StatesEst. completion Jun 30, 2030
Acute Lymphoblastic LeukemiaB-All
Background:
Acute lymphoblastic leukemia (ALL) is a type of blood cancer. Chimeric antigen receptor (CAR) therapy invol…
Bethesda, United StatesEst. completion Jan 31, 2030